http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0704453-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate | 1995-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_172104a2fed162cb9c4dc064382da564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e04f8ca115157fa37159454cd59100 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863e406875e806b23c01bcc684e957d6 |
| publicationDate | 1996-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0704453-A1 |
| titleOfInvention | Novel platinum (ii) complex and remedy for malignant tumor |
| abstract | A novel platinum complex (II) represented by general formula (A) and a remedy for malignant tumor containing the same as the active ingredient, wherein R₁ represents a C₁-C₃ lower hydrocarbon group; R₂ ad R₃ represent each independently hydrogen or a C₁-C₃ lower hydrocarbon group, or R₂ and R₃ may be combined together to represent -(CH₂)₄- or -(CH₂)₅-; Y and Z represent each independently ammonia or a monodentate amine having a C₁-C₇ hydrocarbon group, or Y and Z may be combined together to represent a didentate diamine having a C₂-C₁₀ hydrocarbon group; and X- represents an inorganic acid anion or an organic carboxylic acid anion. This compound is efficacious against cisplatin-resistant cancer, has a solubility suitable for intravenous administration, is stable in aqueous solution, and has an excellent antitumor activity. |
| priorityDate | 1994-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.